首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   241篇
  免费   11篇
  国内免费   1篇
耳鼻咽喉   2篇
儿科学   9篇
妇产科学   18篇
基础医学   25篇
口腔科学   9篇
临床医学   26篇
内科学   52篇
皮肤病学   3篇
神经病学   4篇
特种医学   57篇
外科学   14篇
综合类   11篇
预防医学   6篇
眼科学   1篇
药学   8篇
中国医学   3篇
肿瘤学   5篇
  2019年   3篇
  2018年   2篇
  2016年   5篇
  2015年   6篇
  2014年   4篇
  2013年   8篇
  2012年   5篇
  2010年   5篇
  2009年   4篇
  2008年   4篇
  2007年   6篇
  2006年   4篇
  2005年   3篇
  2004年   2篇
  2003年   4篇
  2002年   3篇
  2001年   4篇
  2000年   1篇
  1999年   3篇
  1998年   20篇
  1997年   13篇
  1996年   12篇
  1995年   14篇
  1994年   7篇
  1993年   16篇
  1992年   2篇
  1991年   4篇
  1990年   3篇
  1989年   9篇
  1988年   5篇
  1987年   5篇
  1986年   4篇
  1985年   5篇
  1984年   2篇
  1983年   2篇
  1982年   3篇
  1981年   2篇
  1980年   7篇
  1978年   2篇
  1977年   2篇
  1976年   4篇
  1975年   2篇
  1959年   2篇
  1958年   2篇
  1957年   6篇
  1956年   4篇
  1955年   4篇
  1954年   5篇
  1950年   2篇
  1949年   1篇
排序方式: 共有253条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
55.
Summary. Background: The development of an inhibitor is the major complication facing patients with hemophilia A treated by administration of factor (F) VIII concentrates. Restoration of tolerance to FVIII can be achieved by prolonged administration of FVIII (immune tolerance induction, ITI). Although ITI has been used for more than 30 years in patients with hemophilia A and inhibitor, its mechanism of action is still poorly understood. Objectives: As administration of high doses of antigen can induce the apoptosis of the T cells recognizing the antigen, a potential mechanism of action of ITI may be the deletion of FVIII‐specific T cells. Patients/Methods: We studied the CD4+ T‐cell response to FVIII in five (one mild, one moderate and three severe) patients successfully desensitized by administration of FVIII and in control subjects. Results: Following repeated stimulation with autologous dendritic cells loaded with FVIII, FVIII‐specific T oligoclonal cell lines were expanded from the blood of one of the successfully desensitized patients. The FVIII‐specific T cells produced IL‐5, IL‐13 and IL‐2. By contrast, FVIII‐specific T‐cell lines could not be derived from three patients with mild hemophilia A without inhibitor or from four normal control subjects. Conclusions: These data represent the first analysis of the cellular mechanisms regulating the induction of tolerance to FVIII. They demonstrate that successful tolerance induction may occur without deletion of FVIII‐specific T cells.  相似文献   
56.
Methodological differences in epidemiologic studies have led to significant discrepancies in injury incidences reported. The aim of this study was to evaluate text messaging as a new method for injury registration in elite female football players and to compare this method with routine medical staff registration. Twelve teams comprising 228 players prospectively recorded injuries and exposure through one competitive football season. Players reported individually by answering three text messages once a week. A designated member of the medical staff conducted concurrent registrations of injuries and exposure. Injuries and exposure were compared between medical staff registrations from nine teams and their 159 affiliated players. During the football season, a total of 232 time‐loss injuries were recorded. Of these, 62% were captured through individual registration only, 10% by the medical staff only, and 28% were reported through both methods. The incidence of training injuries was 3.7 per 1000 player hours when calculated from individual registration vs 2.2 from medical staff registration [rate ratio (RR): 1.7, 1.2–2.4]. For match injuries, the corresponding incidences were 18.6 vs 5.4 (RR: 3.4, 2.4–4.9), respectively. There was moderate agreement for severity classifications in injury cases reported by both methods (kappa correlation coefficient: 0.48, confidence interval: 0.30–0.66).  相似文献   
57.

Background  

There have been few prospective observational studies which recruited older newly-diagnosed cancer patients, and of these only some have reported information on the number needed to screen to recruit their study sample, and the number and reasons for refusal and drop-out. This paper reports on strategies to recruit older newly-diagnosed cancer patients prior to treatment into an observational prospective pilot study and to retain them during a six-month period.  相似文献   
58.
59.
Abstract. The pathobiochemical mechanism of arteriosclerosis in hyperhomocysteinaemia has not yet been elucidated. In vitro studies have shown that the cytotoxic properties of homocysteine can be ascribed to its generation of reactive oxygen species. We studied lipid peroxidation, both in vivo and in vitro , in 10 homozygous cystathionine synthase-deficient (CSD) patients and in a control group of 10 healthy subjects of comparable age and sex. The susceptibility of low-density lipoprotein (LDL) from hyperhomo-cysteinaemic patients to oxidation was determined in vitro by continuously measuring the conjugated diene production induced by incubation with copper ions. Oxidation resistance (expressed as lag time), maximal oxidation rate, and extent of oxidation (expressed as total diene production) of LDL from CSD patients were not significantly different from those of LDL from controls. Furthermore, the time needed to reach maximal diene production, i.e. t(max), was similar for LDL from patients and controls. In addition, the vitamin E concentrations in LDL of CSD patients and controls were similar. The mean concentration (± SD) of plasma thiobarbituric acid reactive substances (TBARS), an indicator of in vivo lipid peroxidation, was 2.2 ± 0.7 μmol L-1 in CSD patients, a lower value than that measured in the matched controls (50± 2.0 μmol L-1). Investigation of in vivo and in vitro parameters of lipid peroxidation shows that the increased risk of arteriosclerosis in hyperhomocysteinaemia is unlikely to be due to increased lipid peroxidation.  相似文献   
60.
Diaphragmatic rupture: CT findings in 11 patients   总被引:7,自引:0,他引:7  
  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号